Clonal deleted latent membrane protein 1 variants of Epstein‐Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cancer

• Publication date

  2016-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.30128PMID 27061907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein-Barr Virus Latent Membrane Protein 1 Genetic Variability in Peripheral Blood B Cells and Oropharyngeal Fluids

  2014cited by this paper
• Epstein-barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids

  2014cited by this paper
• Management of Advanced NK/T-Cell Lymphoma

  2014cited by this paper
• NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1

  2013cited by this paper
• Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populations

  2013cited by this paper
• NK/T-Cell Lymphomas: Pathobiology, Prognosis and Treatment Paradigm

  2012cited by this paper
• Epidemiologic overview of malignant lymphoma

  2012cited by this paper
• EBV LMP1: New and shared pathways to NF-κB activation

  2012cited by this paper
• The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).

  2012cited by this paper
• Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.

  2012cited by this paper
• Genomic Sequencing and Comparative Analysis of Epstein-Barr Virus Genome Isolated from Primary Nasopharyngeal Carcinoma Biopsy

  2012cited by this paper
• Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Κb Activation

  2012cited by this paper
• Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

  2011cited by this paper
• Extranodal natural killer/T-cell lymphoma: advances in the management

  2011cited by this paper
• Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

  2011cited by this paper
• Canonical NF-κB Activation Is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation

  2011cited by this paper
• Distinctive Epstein-Barr Virus Variants Associated with Benign and Malignant Pediatric Pathologies: LMP1 Sequence Characterization and Linkage with Other Viral Gene Polymorphisms

  2011cited by this paper
• The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

  2009cited by this paper
• L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.

  2009cited by this paper
• Comparative analysis of oncogenic properties and nuclear factor-κB activity of latent membrane protein 1 natural variants from Hodgkin’s lymphoma’s Reed-Sternberg cells and normal B-lymphocytes

  2009cited by this paper
• Nasal NK/T-cell lymphoma: epidemiology and pathogenesis

  2008cited by this paper
• Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia

  2008cited by this paper
• Structural variability of the carboxy‐terminus of Epstein–Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas

  2007cited by this paper
• LMP1 Strain Variants: Biological and Molecular Properties

  2006cited by this paper
• Sequence variations of Epstein–Barr virus LMP1 gene in nasal NK/T-cell lymphoma

  2006cited by this paper
• Selective apoptosis of natural killer‐cell tumours by l‐asparaginase

  2005cited by this paper
• High frequency of EBV association and 30‐bp deletion in the LMP‐1 gene in CD56+ lymphomas of the upper aerodigestive tract

  2004cited by this paper
• Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Half-Life in Epithelial Cells Is Down-Regulated by Lytic LMP-1

  2004cited by this paper
• Nasal NK/T Cell Lymphoma in Taiwan: A Clinicopathologic Study of 22 Cases, with Analysis of Histologic Subtypes, Epstein-Barr Virus LMP-1 Gene Association, and Treatment Modalities

  2004cited by this paper
• Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'.

  2004cited by this paper
• Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma

  2004cited by this paper
• Ex Vivo Analysis of T-Cell Responses to Epstein-Barr Virus-Encoded Oncogene Latent Membrane Protein 1 Reveals Highly Conserved Epitope Sequences in Virus Isolates from Diverse Geographic Regions

  2003cited by this paper
• Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

  2003cited by this paper
• Epstein-Barr Virus Latent Membrane Protein 1: Structure and Functions

  2003cited by this paper
• Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.

  2003cited by this paper
• Comparative analysis of NK/T‐cell lymphoma and peripheral T‐cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30‐bp deletion variant LMP1

  2003cited by this paper
• Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.

  2003cited by this paper
• The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China.

  2002cited by this paper
• The Late Lytic LMP-1 Protein of Epstein-Barr Virus Can Negatively Regulate LMP-1 Signaling

  2000cited by this paper
• Ethnic differences in the expression of Epstein-Barr virus latent membrane protein-1 mutations in nasopharyngeal carcinoma.

  2000cited by this paper
• Comparative analysis of Epstein‐Barr virus gene polymorphisms in nasal T/NK‐cell lymphomas and normal nasal tissues: Implications on virus strain selection in malignancy

  1999cited by this paper
• Deletions and single‐base mutations within the carboxy‐terminal region of the latent membrane protein 1 oncogene in Epstein‐Barr virus‐related gastric cancers of Southern Japan

  1999cited by this paper
• Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene.

  1999cited by this paper
• Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma.

  1996cited by this paper
• Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.

  1996cited by this paper
• Nasal NK‐ and T‐cell lymphomas share the same type of Epstein‐Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

  1996cited by this paper
• Epstein‐barr virus (EBV) in malaysian upper‐aerodigestive‐tract lymphoma: Incidence and sub‐type

  1995cited by this paper
• A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.

  1995cited by this paper
• Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma.

  1993cited by this paper
• [The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease].

  1992cited by this paper
• Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.

  1991cited by this paper

• Detection of the 30-bp deletion and protein expression of Epstein-Barr virus latent membrane protein 1 in extranodal NK/T cell lymphoma and its clinicopathological significance

  2025cites this paper
• Nanoarchitectonics-based electrochemical aptasensors for highly efficient exosome detection

  2024cites this paper
• Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma

  2024cites this paper
• Epstein-Barr virus variation in people living with human immunodeficiency virus in southeastern China

  2023cites this paper
• NK-/T-cell lymphomas

  2021cites this paper
• EBV Genome Mutations and Malignant Proliferations

  2020cites this paper
• Genome-Wide Profiling of Epstein–Barr Virus (EBV) Isolated from EBV-Related Malignancies

  2020cites this paper
• Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders

  2019cites this paper
• Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.

  2019cites this paper
• MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma

  2018cites this paper
• Host derived exosomes-pathogens interactions: Potential functions of exosomes in pathogen infection.

  2018cites this paper
• Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma

  2018cites this paper
• NK/T‐CELL LYMPHOMA, THE FRENCH EXPERIENCE.

  2017cites this paper
• LONG‐TERM SURVIVAL AND LOSS IN EXPECTANCY OF LIFE IN A POPULATION‐BASED COHORT OF 7114 PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA

  2017cites this paper
• Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).

  2017cites this paper
• @Becker Digital Commons@Becker

  year unknowncites this paper